Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008
Mon, December 22, 2008

PPD to Present at 27th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. 7th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Tuesday, January 6th 2009 at 13:33 GMT, Last Modified on 2009-01-06 13:33:43 by Market Wire   Print publication without navigation


WILMINGTON, N.C.--([ BUSINESS WIRE ])--PPD, Inc. (NASDAQ:PPDI) today announced that Fred Eshelman, chief executive officer of PPD, will present an update on PPD's business at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Monday, January 12, 2009, at 8:30 a.m. Pacific Standard Time. PPD's presentation will be broadcast live over the Internet and archived shortly after the company's presentation for on-demand replay. All interested parties can access the webcast through the Presentations & Events link in the Investors section of the PPD Web site at [ www.ppdi.com ]. In addition, PPD will make a transcript of the presentation available upon request to its Investor Relations department at +1 910 558 7585.

PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 33 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at [ www.ppdi.com ].


Publication Contributing Sources